GGrantIndex
Sort

25,944 grants matching neurodegeneration

Virus and olfactory system interactions accelerate Alzheimer's disease pathology

$1,032,233
Diego Restrepo · University Of Colorado Denver · R01 · FY2025 · AG

New Mexico Alzheimer's Disease Research Center

$1,030,652
Gary Allen Rosenberg · University Of New Mexico Health Scis Ctr · P20 · FY2021 · AG

Platform to support clinical variant interpretation through probabilistic assessment of functional evidence

$1,030,156
Nicholas Schafer · Constantiam Biosciences Inc. · R44 · FY2025 · HG

Pathogenesis Of Diseases Induced By Non-oncogenic Retroviruses

$1,029,781
John Portis · Niaid Extramural Activities · Z01 · FY2007 · AI

Investigating the role of TDP-43 mislocalization, structure, and post-translational modifications in the neuropathologically heterogeneous TDP-43 proteinopathies

$1,029,657
Kathy L Newell · Indiana University Indianapolis · R01 · FY2024 · NS

Deep Dive: Mapping the Neuropathology of Essential Tremor and Exploring the Molecular Underpinnings of Neurodegeneration

$1,028,252
Phyllis L Faust · Columbia University Health Sciences · R01 · FY2021 · NS

Mitigation of Neurological Damage Following Seizures

$1,028,186
Pamela J Lein · University Of California At Davis · U54 · FY2018 · NS

Role of Microglia somatic variants in Neurodegenerative diseases

$1,027,639
Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2020 · NS

Development of a Synthetic, Cell-Permeable Peptide for the Inhibition of CDK5-p25 Hyperactivity in Amyotrophic Lateral Sclerosis

$1,027,314
John Kent Werner · Cogentis Therapeutics, Inc. · R44 · FY2022 · NS

Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease

$1,027,273
Aaron D. Gitler · Stanford University · R35 · FY2019 · NS

Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease

$1,027,273
Aaron D. Gitler · Stanford University · R35 · FY2018 · NS

Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease

$1,027,273
Aaron D. Gitler · Stanford University · R35 · FY2022 · NS

Role of Innate Immune Dysregulation in the Etiology of Dementia

$1,026,477
Annelise Emily Barron · Stanford University · DP1 · FY2021 · AG

Regulation and functional effects of localized RNAs

$1,025,854
Stavroula Mili · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Integrated Center for In Vivo Microscopy

$1,025,232
George Allan Johnson · Duke University · P41 · FY2006 · RR

Restoration of olfactory neural circuitry following disruption.

$1,024,907
Leonardo Belluscio · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS

Neuroimaging and Plasma Biomarkers Core

$1,024,654
Ilya M Nasrallah · Columbia University Health Sciences · U19 · FY2024 · AG

Mitigation of Neurological Damage Following Seizures

$1,023,165
Pamela J Lein · University Of California At Davis · U54 · FY2019 · NS

Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer

$1,023,150
Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R35 · FY2024 · CA

Spatial analysis of regional, cell type and molecular hallmarks of Alzheimer's disease

$1,022,666
Ed Lein · Allen Institute · U19 · FY2020 · AG

Biology of Prion Protein and the TSE Diseases

$1,020,638
Bruce Chesebro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

NEUROSCIENCE CORE CENTER

$1,020,517
Francis W Flynn · University Of Wyoming · P30 · FY2011 · RR

NEUROSCIENCE CORE CENTER

$1,020,517
Francis W Flynn · University Of Wyoming · P30 · FY2011 · RR

Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk

$1,019,526
Craig C Weinkauf · University Of Arizona · R01 · FY2022 · AG

Mitigation of Neurological Damage Following Seizures

$1,019,174
Pamela J Lein · University Of California At Davis · U54 · FY2020 · NS